Improving Clinical Outcomes In Impairment Studies

Industry standard timelines for end-to-end completion of a typical renal or hepatic impairment trial may be up to 18-22 months. Over the past 10 years, Covance has developed a built-for-purpose model for executing impairment studies resulting in a 36% reduction of time for end-to-end services. Watch this webinar to learn about the three pillars that can positively influence your clinical trial outcome